6 unchanged sentences
Securities Authorized for Issuance under Equity Compensation Plans
−Removed: “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.”
+Added: “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” of this Annual Report.
Recent Sale of Unregistered Securities and Use of Proceeds
+Added: Issuer Purchases of Equity Securities
+Added: On February 20, 2023, the Company’s Board of Directors approved a share repurchase program of up to an aggregate $250.0 million of common stock of the Company.
+Added: On December 6, 2023, the Company’s Board of Directors approved an increase to its stock repurchase program authorization from $250.0 million to $500 million.
+Added: This program has no specified expiration date.
+Added: The following table provides certain information with respect to the Company’s repurchases of common stock from October 1, 2023 through December 31, 2023:
+Added: Period Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
+Added: October 1, 2023 - October 31, 2023 — $ — — $ 75,000,067
+Added: November 1, 2023 - November 30, 2023 1,620,021 28.78 1,620,021 28,368,824
+Added: December 1, 2023 - December 31, 2023 937,594 30.26 937,594 250,000,103
+Added: 2,557,615 $ 29.32 2,557,615 $ 250,000,103
Stock Performance Graph
−Removed: The following graph compares the total cumulative returns of BioScrip through August 6, 2019 and Option Care Health from August 7, 2019 through December 31, 2022 with the total cumulative returns of the Nasdaq Composite Index, Nasdaq Health Services Index, and the S&P Health Care Services Select Industry Index for the five-year period from December 31, 2017 through December 31, 2022.
−Removed: The Company included the S&P Health Care Services Select Industry Index as an industry benchmark comparison for the year ended December 31, 2022 as it more accurately represents a true benchmark of the Company’s peer group and will align to our definitive proxy statement to be filed with the SEC no later than 120 days after December 31, 2022.
−Removed: The Company may consider transitioning away from the use of the Nasdaq Health Services Index as a comparative index in future Annual Reports.
+Added: The following graph compares the total cumulative returns of BioScrip through August 6, 2019 and Option Care Health from August 7, 2019 through December 31, 2023 with the total cumulative returns of the Nasdaq Composite Index and the S&P Health Care Services Select Industry Index for the five-year period from December 31, 2018 through December 31, 2023.
The graph shows the performance of a $100 investment in our Common Stock and each index as of December 31, 2018.
+Added: * $100 invested on December 31, 2018 in stock or index, including reinvestment of dividends.
Year Ended December 31,
3 unchanged sentences
Nasdaq Composite Index $ 100.00 $ 135.23 $ 194.24 $ 235.78 $ 157.74 $ 226.24
−Removed: Nasdaq Health Services Index $ 100.00 $ 95.83 $ 120.59 $ 156.81 $ 151.25 $ 120.35
S&P Health Care Services Select Industry Index $ 100.00 $ 118.40 $ 157.48 $ 172.35 $ 137.77 $ 144.10
−Removed: * $100 invested on December 31, 2017 in stock or index, including reinvestment of dividends.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.